1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)
  4. Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/220131
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHeras, Marta-
dc.contributor.authorAzcona, Leticia-
dc.contributor.authorArencibia, Octavio-
dc.contributor.authorMinig, Lucas-
dc.contributor.authorMartí, Lola-
dc.contributor.authorHernandez, Alicia-
dc.contributor.authorLekuona, Arantxa-
dc.contributor.authorÑiguez, Isabel-
dc.contributor.authorGil Ibañez, Blanca-
dc.contributor.authorDíaz Feijoo, Berta-
dc.contributor.authorRibot, Laia-
dc.contributor.authorCabezas, Maria Nieves-
dc.contributor.authorLamarca, Marta-
dc.contributor.authorBellón, Mónica-
dc.contributor.authorAlkourdi, Amira-
dc.contributor.authorCárdenas, Laura-
dc.contributor.authorBoldo, Ana-
dc.contributor.authorAmengual, Joana-
dc.contributor.authorGorostidi, Mikel-
dc.contributor.authorZapardiel, Ignacio-
dc.date.accessioned2025-03-31T10:25:04Z-
dc.date.available2025-03-31T10:25:04Z-
dc.date.issued2023-09-01-
dc.identifier.issn1048-891X-
dc.identifier.urihttps://hdl.handle.net/2445/220131-
dc.descriptionComunicació/presentació a: 24th European Congress on Gynaecological Oncology, European Society of Gynaecological Oncology, Istanbul, 28 setembre -1 octubre 2023-
dc.description.abstractTo assess the safety of fertility sparing treatments for early-stage ovarian cancer in women younger than 45 years.-
dc.format.extent1 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBMJ Publishing Group Ltd-
dc.relation.isformatofReproducció del document publicat a: https://www.sciencedirect.com/science/article/pii/S1048891X25004736-
dc.relation.ispartofInternational Journal of Gynecological Cancer, 2023, vol. 33, sup. 3, p. A270-
dc.relation.urihttps://www.sciencedirect.com/science/article/pii/S1048891X25004736-
dc.rightscc-by-nc-nd (c) IGCS, ESGO, 2023-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceComunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationCàncer d'ovari-
dc.subject.classificationFecunditat-
dc.subject.classificationTerapèutica-
dc.subject.otherOvarian cancer-
dc.subject.otherFertility-
dc.subject.otherTherapeutics-
dc.titleOncological safety of fertility preservation treatment in ovarian cancer-
dc.typeinfo:eu-repo/semantics/conferenceObject-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2024-10-16T08:22:19Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
A270.1.full.pdf218.55 kBAdobe PDFView/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons